Table 1.
Characteristics of discordant population
| Characteristic | Frequency (%) |
|---|---|
| Age (years) | |
| 6-20 | 5 (10.48) |
| 21-40 | 20 (41.66) |
| 41-60 | 19 (39.5) |
| >60 | 4 (8.33) |
| Gender | |
| Male | 24 (50) |
| Female | 23 (47.9) |
| Transgender | 1 (2.1) |
| Immunological nonresponse | |
| Males | 18 (37.5) |
| Females | 17 (35.4) |
| Transgender | 1 (2.1) |
| Total | 36 (75) |
| Virological nonresponse | |
| Males | 6 (12.5) |
| Females | 6 (12.5) |
| Total | 12 (25) |
| Opportunistic infections/chronic disease/co-infection | |
| Tuberculosis | 5 (10.4) |
| Syphilis | 1 (2.1) |
| Chronic HBV infection | 2 (4.2) |
| Chronic kidney disease | 2 (4.2) |
| Adherence (%) | |
| >95 | 34 (70.8) |
| <95 | 14 (29.2) |
| Mean baseline CD4 value (cells/mm3) | |
| Immunological nonresponse | 219 |
| Virological nonresponse | 306 |
| Mean duration of follow-up (years) | |
| Immunological nonresponse | 2.99 |
| Virological nonresponse | 3.26 |
| Baseline ART regimen | |
| TDF + 3TC + EFV/DTG | 43 (89.5) |
| AZT + 3TC + NVP | 2 (4.2) |
| ABC + 3 TC + EFV/DTG | 2 (4.2) |
| AZT + 3TC + ATV/R | 1 (2.1) |
HBV=Hepatitis B virus; ART=Antiretroviral therapy